Concetta Quintarelli

15PUBLICATIONS
98CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targetsAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Mar 03, 2026
Anti-CD7 fratricide-resistant chimeric antigen receptor T cells for relapsed/refractory acute myeloid leukemia.

Marco Becilli, Pietro Merli, Mattia Algeri

|Aug 19, 2025
International consensus guidelines for the conduct and reporting of CAR T-cell clinical trials in AML.

Swati Naik, Richard Aplenc, Susanne H C Baumeister

|Jun 25, 2025
Point-of-care fresh CAR T cells for pediatric or young adult BCP-ALL that is relapsed/refractory or in very-high-risk first relapse.

Francesca Del Bufalo, Marco Becilli, Chiara Rosignoli

|Jun 13, 2024
GD2 Target Antigen and CAR T Cells: Does It Take More Than Two to Tango?

Franco Locatelli, Concetta Quintarelli

|Mar 29, 2024
GD2-Targeting CAR T-cell Therapy for Patients with GD2+ Medulloblastoma.

Roselia Ciccone, Concetta Quintarelli, Antonio Camera

|May 12, 2023
Allogeneic, donor-derived, second-generation, CD19-directed CAR-T cells for the treatment of pediatric relapsed/refractory BCP-ALL.

Francesca Del Bufalo, Marco Becilli, Chiara Rosignoli

Pageof 3

Frequent Collaborators

7 joint publications

Biagio De Angelis

7 joint publications

Franco Locatelli

7 joint publications

Francesca Del Bufalo

4 joint publications

Stefano Di Cecca